Teacher Retirement System Of Texas Akebia Therapeutics, Inc. Transaction History

Teacher Retirement System Of Texas

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.32 - $0.67 $2,468 - $5,169	-7,715 Reduced 23.06%	25,737 $9,000
Q1 2022 May 09, 2022	BUY	$0.72 - $2.93 $839 - $3,416	1,166 Added 3.61%	33,452 $24,000
Q4 2021 Feb 10, 2022	BUY	$2.26 - $3.34 $19,795 - $29,255	8,759 Added 37.23%	32,286 $73,000
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.88 $15,427 - $25,472	6,565 Added 38.7%	23,527 $68,000
Q2 2021 Aug 05, 2021	BUY	$2.83 - $4.2 $7,609 - $11,293	2,689 Added 18.84%	16,962 $64,000
Q1 2021 May 11, 2021	BUY	$2.92 - $5.06 $8,246 - $14,289	2,824 Added 24.67%	14,273 $48,000
Q4 2020 Feb 11, 2021	BUY	$2.22 - $3.78 $25,416 - $43,277	11,449 New	11,449 $32,000
Q1 2018 May 08, 2018	SELL	$9.53 - $15.68 $120,468 - $198,210	-12,641 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$14.24 - $19.59 $180,007 - $247,637	12,641	12,641 $188,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $438M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.